8 results
Tuberculosis Overview

10 million new M. tuberculosis infections/year
Facultative intracellular rod-shaped bacteria
Multidrug-resistant tuberculosis (MDR-TB) accounts for 4.6% of
(LTBI) Pathophysiology ... (Anorexia) • Night ... Active TB: • ... Treatment: Active ... #Management #Treatment
Tuberculosis Overview

10 million new M. tuberculosis infections/year
Facultative intracellular rod-shaped bacteria
Multidrug-resistant tuberculosis (MDR-TB) accounts for 4.6% of
(LTBI) Pathophysiology ... (Anorexia) • Night ... Active TB: • ... Treatment: Active ... #Management #Treatment
IDSA Recommendations for Treating Mycobacterium Tuberculosis Infection and Disease in HIV-AIDS
Treating LTBI (to prevent TB disease)
Indications:
Mycobacterium Tuberculosis ... no evidence of active ... Mycobacterium #Tuberculosis ... opportunistic #infections #HIVAIDS ... #pharmacology
IDSA - Clinical Strategy to Build an Individualized Treatment Regimen for Multi-Drug Resistant Tuberculosis (MDR-TB)
 •
Individualized Treatment ... Multi-Drug Resistant Tuberculosis ... 1: Choose one later-generation ... MDRTB #management #Treatment ... antimicrobials #regimens #pharmacology
Lung Abscess - Diagnosis and Management Summary

Lung Abscess Etiology:
 • Necrosis of lung parenchyma by a
Lung Abscess Pathophysiology ... degrees • Chills, night ... weight loss • Late ... CXR upright or lat ... westermani • Other: TB
TB
This patient presented first with the CXR on the left.
The findings are:
Widespread ill-defined densities, which are
TB This patient ... was positive for TB ... CXR some years later ... Radiology #CXR #Tuberculosis ... #TB #Active #SecondaryTB
Digoxin Pharmacology and Pathophysiology
1) Na/K ATPase Pump - Digoxin works by directly binding to and inhibiting
Digoxin Pharmacology ... and Pathophysiology ... Decreased heart rate ... within normal limits ... #Pathophysiology
IDSA Recommendations for Preventing and Treating Disseminated Mycobacterium Avium Complex in HIV-AIDS
Preventing 1st Episode of Disseminated
Note: Active TB ... IDSA #Prevention #Treatment ... opportunistic #infections #HIVAIDS ... #pharmacology